Reckitt

Reckitt has lowered its growth expectations for 2026 and now expects like-for-like sales for core brands to rise by 3.5–4.5 percent, each 0.5 percentage points lower than previously. The reason is supply bottlenecks for cleaning products in the US (Lysol) and a setback with vitamin products in China, which temporarily curtailed production. In the third quarter, like-for-like core sales rose 3.3 percent to around £2.7 billion, and the share price fell sharply after the news. » More on finanzen.net

At the Barclays conference Reckitt highlighted its unanimous victory in the MDL proceedings over infant formula, viewing it as validation of its scientific position. Management confirmed the outlook for 4–5% organic core growth and pointed to strong momentum in emerging markets and an improved innovation pipeline. Reckitt is considering strategic options for Mead Johnson but rules out a formal sale process and says it will not accept prices that would require impairment. Price adjustments, further cost cuts via Global Business Services and AI, and a stabilization in Europe should support growth. » More on de.investing.com

Reckitt shares climbed more than 4% after a unanimous US district court verdict in the first landmark NEC case against subsidiary Mead Johnson, leaving no outstanding jury verdicts in the NEC suits against Mead Johnson. Additional support came from JPMorgan’s upgrade to "Overweight" and a raised price target from 5,800 to 6,500 pence for December 2027; the bank sees stronger prospects for the core business alongside reduced legal risk. Reckitt continues to explore options for Mead Johnson after already divesting the Essential Home division, and JPMorgan raised its organic growth forecasts for 2026 and 2027. » More on de.investing.com

Reckitt has successfully completed the buyback offer by its subsidiary Mead Johnson for the 2044 senior notes: senior notes with a 4.600% coupon and an aggregate principal amount of USD 400.4 million were tendered, for USD 898.00 per USD 1,000 principal plus accrued interest. After the expected settlement on 18 August 2026, notes with a principal amount of USD 99.6 million will remain outstanding. Mead Johnson obtained the necessary consents to amend the indenture, which removes nearly all covenants and releases Reckitt from its guarantee; a supplemental indenture is to become effective on the settlement date. » More on de.investing.com

Mead Johnson is offering to repurchase all outstanding 4.600% senior notes due 2044 with a principal amount of $500 million and is simultaneously seeking consent to amendments to the note terms that would remove covenants and release Reckitt’s guarantee. The offer runs until August 13, 2026; the expected settlement date is August 18, 2026. The consideration will be set at a fixed spread of 30 basis points over the yield of the 5.000% U.S. Treasury (May 15, 2046) plus accrued interest; consent requires tendering the notes and a simple majority of the outstanding principal. Notes not tendered will remain outstanding and will be subject to the amended terms if the amendments become effective. » More on de.investing.com